Placental growth factor as a target for the treatment of osteoporosis
Patent Number: 7,357,929
Date of First Priority Issue: Friday June 28th, 2002
Date Issued: Tuesday April 15th, 2008
Assignee: D. Collen Research Foundation VZW (Leuven, BE)
Inventors: Carmeliet; Peter (Blanden, BE), Collen; Desire (Winksele, BE), Bouillon; Roger (Winksele, BE), Carmeliet; Gertrudis (Blanden, BE)
From Class: Use
Comments: 1 (Show Comments)
This patent covers the inhibition of placental growth factor as a method of treating osteoporosis. The one issued claim is restricted to inhibition of placental growth factor using an antibody or fragments of the antibody.
The inventor demonstrated inhibition of bone resorption in an animal model, as well as in vitro using anti-placental growth factor antibodies. Interestingly in the examples the use of mesenchymal stem cells together with this antibody are also described.
View this patent on the USPTO website.
Added to StemCellPatents.com on Sunday April 20th, 2008
Social & Bookmarking:
1 Comment | Add Comment
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.
Christineball33 said...